Evidence map›Paper›PMID 36262101›Full record

ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2023

Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?

Murat Kantarcıoğlu, Gülşen Yıldırım, Pınar Akpınar Oktar, Serpil Yanbakan, Zeynep Büşra Özer, Deniz Yurtsever Sarıca, Serpil Taşdelen, Emel Bayrak, Dilara Fatma Akın Balı, Seçkin Öztürk and 3 more

Open access · diamondAbstract read
In one paragraph

Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Emerging Role of Plant-Derived Nanostructures in Nanomedicine.International journal of nanomedicine · 2025
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Murat KantarcıoğluLÖSEV LÖSANTE Hospital, Ankara, Turkey.
Gülşen YıldırımLÖSEV LÖSANTE Hospital, Ankara, Turkey.
Pınar Akpınar OktarLÖSEV LÖSANTE Hospital, Ankara, Turkey.
Serpil YanbakanLÖSEV LÖSANTE Hospital, Ankara, Turkey.
Zeynep Büşra ÖzerAnkara University Stem Cell Institute, Ankara, Turkey.
Deniz Yurtsever SarıcaLÖSEV LÖSANTE Hospital, Ankara, Turkey.
Serpil TaşdelenLÖSEV LÖSANTE Hospital, Ankara, Turkey.
Emel BayrakLÖSEV LÖSANTE Hospital, Ankara, Turkey.
Dilara Fatma Akın BalıDepartment of Medical Biology, Niğde Ömer Halis University Faculty of Medicine, Niğde, Turkey.
Seçkin ÖztürkMiddle East Technical University, Ankara, Turkey.
Kamil Can AkçalıAnkara University Stem Cell Institute, Ankara, Turkey.
Üstün EzerLÖSEV LÖSANTE Hospital, Ankara, Turkey.
Ahmet Emin KürekçiLÖSEV LÖSANTE Hospital, Ankara, Turkey.
Memorial Ankara Hospital · TRAnkara University · TRMiddle East Technical University · TRNiğde Ömer Halisdemir Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRegular coffee consumption has beneficial and preventative effects on liver and chronic neurodegenerative diseases. However, the studies performed with the ingredients found in coffee beverages have not clarified the responsible mechanisms. Exosomes are small, membrane-coated cargo packages secreted by prokaryote and eukaryote cells. Exosomes regulate intercellular communication and affect cellular metabolic activities even among different species. In this study, we aimed to isolate and characterize the edible plant-derived exosome-like nanoparticles from roasted hot coffee beverages, hypothesizing that the edible plant-derived exosome-like nanoparticles were responsible for the beneficial effects of coffee.

methodsSize exclusion chromatography and commercial kits were used for the isolation process. Efficient coffee edible plant-derived exosome-like nanoparticle fractions were determined by an ultraviolet-visible spectrophotometer. Harvested coffee edible plant-derived exosome-like nanoparticles were characterized by transmission electron microscopy. The quantification procedure was performed using a commercial kit. Coffee edible plant-derived exosome-like nanoparticles' proliferative effects on human hepatic stellate cells and human hepatocellular carcinoma cells were studied using an MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) assay. Whole-exosome RNA sequencing was performed.

resultsTransmission electron microscopy scanning analysis indicated round-shaped nanoparticles with sizes ranging from 40 to 100 nm. Both size exclusion chromatography and kit-isolated edible plant-derived exosome-like nanoparticle samples showed maximum absorbance at 227.5 nm in ultraviolet-visible spectrophotometer analysis. Regarding the quantitation results, kit isolation was more efficient than the size exclusion chromatography method when the harvested particle numbers were compared. An important MTT assay finding confirmed the observed beneficial effects of coffee beverages: coffee edible plant-derived exosome-like nanoparticles significantly suppressed hepatocellular carcinoma cell proliferation. As a result of sequencing, we identified 15 mature miRNAs. A MapReduce-based MicroRNA Target Prediction Method (The DIANA tools' MR-microT algorithm) highlighted 2 genes specifically associated with the miRNAs that we obtained: KMT2C and ZNF773.

conclusionFor the first time in the literature, coffee edible plant-derived exosome-like nanoparticles were identified. These nanoparticles may have therapeutic effects on chronic liver diseases. Experimental studies, therefore, should be performed on disease models to demonstrate their efficacy.

Indexed as

Carcinoma, HepatocellularExosomesLiver NeoplasmsMicroRNAsNanoparticlesCoffeeHumansCoffeeMicroRNAs

Identifiers

PMID36262101
PMCPMC10081033
OpenAlexW4306769999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.